Skip to main content

Table 1 Baseline characteristics of the study participants

From: Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community

Subject characteristics N = 103 (%)
Age, mean ± SD, years 78.19 ± 6.87
Male sex 31 (29.66)
Literate 83 (80.58)
Live alone 37 (35.92)
Smoking
 Never 80(77.67)
 Quitted 19(18.45)
 Current 2(1.94)
 Unknown 2(1.94)
Exercise Habit
Amount per week,mean ± SD, minutes 243.43 ± 202,19
 - Less than 150 min per day 36(34.95)
  − 150 min or above 62 (60.19)
 - Unknown 5 (4.85)
Disease Status at baseline visit
Uncontrolled blood pressure level 57 (55.34)
 - Stage II Hypertensiona 19/57 (33.33)
Uncontrolled RCBG levelb 20(19.42)
Uncontrolled cholesterol levels 56(54.37)
 - Uncontrolled LDL-C levelc 21/56(37.50)
 - Uncontrolled TG leveld 46/56 (82.14)
 - Both uncontrolled LDL-C and TG levels 11/56(19.64)
Present with symptoms of heart failure corresponding to NYIIA Functional Classification system 87 (84.47)
Medical history
Hypertension 97 (94.17)
Diabetes mellitus 44 (42.72)
Hyperlipidemia 76(73.79)
Coronary Heart Disease 20(19.42)
Heart failure 4(3.88)
Stroke 13(12.62)
Medications
Number of chronic medications, mean ± SD 5.08 ± 3.02
  1. a: Non-stage II - Systolic blood pressure < 160mmHg Or Diastolic blood pressure < 100mmHg
  2. Stage II - Systolic blood pressure160mmHg Or Diastolic blood pressure100mmHg (JNC 7 Guideline [13])
  3. b: Uncontrolled RCBG level: ≥ 11.1 mmol/L (ADA [14])
  4. c: Uncontrolled LDL-C level: ≥ 2.59 mmol/L (ATP III [15])
  5. d: Uncontrolled TG level : ≥ 2.3mmol/L (ATP III [15])